(Q24299238)

response to interleukin-6

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author

Bente Klarlund Pedersen

5

0 references

Peter Plomgaard

object named as

Peter Plomgaard

2

0 references

author name string

Anders R Nielsen

1

0 references

Karen S Krabbe

3

0 references

Julia S Johansen

Elevated plasma YKL-40 levels and ischemic stroke in the general population

4

0 references

language of work or name

English

0 references

publication date

July 2011

0 references

published in

Cytokine

0 references

volume

55

0 references

issue

1

0 references

page(s)

152-5

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Regulation of synthesis of complement proteins in HEp2 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

YKL-40 protein expression in normal adult human tissues--an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Hormonal regulation of complement biosynthesis in human cell lines--II. Upregulation of the biosynthesis of complement components C3, factor B and C1 inhibitor by interleukin-6 and interleukin-1 in human hepatoma cell line.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Inflammatory mediators in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Serum YKL-40 is increased in patients with hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Cytokine regulation of the acute-phase protein levels in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

A chitinase-like protein in the lung and circulation of patients with severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Structure and ligand-induced conformational change of the 39-kDa glycoprotein from human articular chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Circulating YKL-40 levels during human endotoxaemia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Serum YKL-40, a new prognostic biomarker in cancer patients?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Interleukin-6 stimulates lipolysis and fat oxidation in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Plasma YKL-40: a BMI-independent marker of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2011.03.014

7 January 2021

10.1016/J.CYTO.2011.03.014

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

3596407

3596407

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference